James Loerop - Chief Business Officer at Aclaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
ACRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Loerop since 12/1/2024

Holdings reported by James Loerop for Aclaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 103K $256K $2.48 Feb 1, 2025 Direct
Restricted Stock Units 83.5K $207K $2.48 Feb 3, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 292K Feb 3, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 207K Feb 1, 2024 Direct Common Stock
Resticted Stock Units 15K Feb 1, 2025 Direct Common Stock

Transactions reported by James Loerop for Aclaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.